
    
      The study is designed as an observational post-market follow-up study, to confirm the
      performance of the medical device in real life conditions and document its safety profile.

      The eligible population corresponds to the population that could benefit from the treatment,
      according to the MD's instructions for use. Non-inclusion criteria prevent from including
      patients with other pathologies associated with gastro-intestinal troubles, who may
      beneficiate from more adequate treatments.
    
  